Vinblastine (patient information): Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
mNo edit summary
 
(25 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{DrugProjectFormSinglePage
|authorTag=


{{drug header}}
{{SI}}


<!--Overview-->
==IMPORTANT WARNING:==
When vinblastine is administered into a vein, it may leak into surrounding tissue. Your doctor or nurse will monitor your administration site for this reaction.
==About your treatment==
Your doctor has ordered the drug vinblastine to help treat your illness. The drug is given by injection into a vein.


|genericName=
'''This medication is used to treat:'''


*Hodgkin's disease
*non-Hodgkin's lymphomas
*mycosis fungoides
*testicular cancer
*Kaposi's sarcoma related to acquired immunodeficiency syndrome (AIDS)
*Letterer-Siwe disease


This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.


|aOrAn=
Vinblastine is in a class of drugs known as vinca alkaloids. It slows or stops the growth of cancer cells in your body. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.


a
==Other uses for this medicine==
Vinblastine is also used to treat non-small cell lung cancer, bladder cancer, head and neck cancer, cervical cancer, idiopathic thrombocytopenia purpura, and autoimmune hemolytic anemia. Talk to your doctor about the possible risks of using this drug for your condition.


|drugClass=
==Precautions==
'''Before taking vinblastine'''


*tell your doctor and pharmacist if you are allergic to vinblastine or any other drugs.
*tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially aspirin, itraconazole (Sporanox), phenytoin (Dilantin), and vitamins.
*tell your doctor if you have or have ever had liver disease.
you should know that vinblastine may interfere with the normal menstrual cycle (period) in women and may stop sperm production in men. However, you should not assume that you cannot get pregnant or that you cannot get someone else pregnant. Women who are pregnant or breast-feeding should tell their doctors before they begin taking this drug. You should not plan to have children while receiving chemotherapy or for a while after treatments. (Talk to your doctor for further details.) Use a reliable method of birth control to prevent pregnancy. Vinblastine may harm the fetus.
*do not have any vaccinations (e.g., measles or flu shots) without talking to your doctor.


==Side Effects==
===Mild side effects===
''Side effects from vinblastine are common and include:''


|indication=
*nausea and vomiting which usually lasts less than 24 hours
*stomach pain
*constipation
*diarrhea
*jaw pain, headache, or other aches
*thinned or brittle hair
*exposed areas of the skin may become easily sunburned


''Tell your doctor if either of these symptoms is severe or lasts for several hours:''


*fatigue
*mouth blistering


|hasBlackBoxWarning=
===Severe side effects===
''If you experience any of the following symptoms, call your doctor immediately:''


Yes
*unusual bleeding or bruising
*tingling, numbness, and cramping in the legs or arms for longer than a few days
*severe abdominal or muscle cramping
*difficulty walking
*hoarseness
*fever
*chills
*change in normal bowel habits for more than 2 days
*sore throat or mouth
*difficulty controlling bladder
*increased, painful, or difficult urination
*redness, pain, or swelling at the injection site


|adverseReactions=
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/report.htm] or by phone [1-800-332-1088].


==In case of emergency/overdose==
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.


==Special instructions==
The most common side effect of vinblastine is a decrease of blood cells. Your doctor may order tests before, during, and after your treatment to see if your blood cells are affected by the drug.


<!--Black Box Warning-->
==Brand names==
*Velban®


|blackBoxWarningTitle=
Title


|blackBoxWarningBody=
[[Category:Oncology Drugs]]
<i><span style="color:#FF0000;">ConditionName: </span></i>
[[Category:Immunosuppressive Drugs]]


* Content
{{WH}}
 
{{WikiDoc Sources}}
<!--Adult Indications and Dosage-->
 
<!--FDA-Labeled Indications and Dosage (Adult)-->
 
|fdaLIADAdult=
 
=====Condition1=====
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
* Dosing Information
 
:* Dosage
 
=====Condition3=====
 
* Dosing Information
 
:* Dosage
 
=====Condition4=====
 
* Dosing Information
 
:* Dosage
 
<!--Off-Label Use and Dosage (Adult)-->
 
<!--Guideline-Supported Use (Adult)-->
 
|offLabelAdultGuideSupport=
 
=====Condition1=====
 
* Developed by:
 
* Class of Recommendation:
 
* Strength of Evidence:
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 
<!--Non–Guideline-Supported Use (Adult)-->
 
|offLabelAdultNoGuideSupport=
 
=====Condition1=====
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 
<!--Pediatric Indications and Dosage-->
 
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
 
|fdaLIADPed=
 
=====Condition1=====
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Off-Label Use and Dosage (Pediatric)-->
 
<!--Guideline-Supported Use (Pediatric)-->
 
|offLabelPedGuideSupport=
 
=====Condition1=====
 
* Developed by:
 
* Class of Recommendation:
 
* Strength of Evidence:
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Non–Guideline-Supported Use (Pediatric)-->
 
|offLabelPedNoGuideSupport=
 
=====Condition1=====
 
* Dosing Information
 
:* Dosage
 
=====Condition2=====
 
There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 
<!--Contraindications-->
 
|contraindications=
 
* Condition1
 
<!--Warnings-->
 
|warnings=
 
* Description
 
====Precautions====
 
* Description
 
<!--Adverse Reactions-->
 
<!--Clinical Trials Experience-->
 
|clinicalTrials=
 
There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
 
=====Body as a Whole=====
 
 
 
 
=====Cardiovascular=====
 
 
 
 
=====Digestive=====
 
 
 
 
=====Endocrine=====
 
 
 
 
=====Hematologic and Lymphatic=====
 
 
 
 
=====Metabolic and Nutritional=====
 
 
 
 
=====Musculoskeletal=====
 
 
 
 
=====Neurologic=====
 
 
 
 
=====Respiratory=====
 
 
 
 
=====Skin and Hypersensitivy Reactions=====
 
 
 
 
=====Special Senses=====
 
 
 
 
=====Urogenital=====
 
 
 
 
=====Miscellaneous=====
 
 
 
<!--Postmarketing Experience-->
 
|postmarketing=
 
There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
 
=====Body as a Whole=====
 
 
 
=====Cardiovascular=====
 
 
 
=====Digestive=====
 
 
 
=====Endocrine=====
 
 
 
=====Hematologic and Lymphatic=====
 
 
 
=====Metabolic and Nutritional=====
 
 
 
=====Musculoskeletal=====
 
 
 
=====Neurologic=====
 
 
 
=====Respiratory=====
 
 
 
=====Skin and Hypersensitivy Reactions=====
 
 
 
=====Special Senses=====
 
 
 
=====Urogenital=====
 
 
 
=====Miscellaneous=====
 
 
 
<!--Drug Interactions-->
 
|drugInteractions=
 
* Drug
:* Description
 
<!--Use in Specific Populations-->
 
|useInPregnancyFDA=
* '''Pregnancy Category'''
 
|useInPregnancyAUS=
* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
 
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
 
|useInLaborDelivery=
There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
 
|useInNursing=
There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
 
|useInPed=
There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
 
|useInGeri=
There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
 
|useInGender=
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
 
|useInRace=
There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
 
|useInRenalImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
 
|useInHepaticImpair=
There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
 
|useInReproPotential=
There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
 
|useInImmunocomp=
There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
 
<!--Administration and Monitoring-->
 
|administration=
 
* Oral
 
* Intravenous
 
|monitoring=
 
There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
 
* Description
 
<!--IV Compatibility-->
 
|IVCompat=
 
There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
 
<!--Overdosage-->
 
|overdose=
 
===Acute Overdose===
 
====Signs and Symptoms====
 
* Description
 
====Management====
 
* Description
 
===Chronic Overdose===
 
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
 
<!--Pharmacology-->
 
<!--Drug box 2-->
 
|drugBox=
 
 
 
<!--Mechanism of Action-->
 
|mechAction=
 
*
 
<!--Structure-->
 
|structure=
 
*
 
: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
 
<!--Pharmacodynamics-->
 
|PD=
 
There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
 
<!--Pharmacokinetics-->
 
|PK=
 
There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
 
<!--Nonclinical Toxicology-->
 
|nonClinToxic=
 
There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
 
<!--Clinical Studies-->
 
|clinicalStudies=
 
There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
 
<!--How Supplied-->
 
|howSupplied=
 
*
 
<!--Patient Counseling Information-->
 
|fdaPatientInfo=
 
There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
 
<!--Precautions with Alcohol-->
 
|alcohol=
 
* Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
 
<!--Brand Names-->
 
|brandNames=
 
* ®<ref>{{Cite web | title =  | url =  }}</ref>
 
<!--Look-Alike Drug Names-->
 
|lookAlike=
 
* A® — B®<ref name="www.ismp.org">{{Cite web  | last =  | first =  | title = http://www.ismp.org | url = http://www.ismp.org | publisher =  | date =  }}</ref>
 
<!--Drug Shortage Status-->
 
|drugShortage=
}}
 
<!--Pill Image-->
 
{{PillImage
|fileName=No image.jpg|This image is provided by the National Library of Medicine.
|drugName=
|NDC=
|drugAuthor=
|ingredients=
|pillImprint=
|dosageValue=
|dosageUnit=
|pillColor=
|pillShape=
|pillSize=
|pillScore=
}}
 
<!--Label Display Image-->
 
{{LabelImage
|fileName={{PAGENAME}}11.png|This image is provided by the National Library of Medicine.
}}
 
{{LabelImage
|fileName={{PAGENAME}}11.png|This image is provided by the National Library of Medicine.
}}
 
<!--Category-->
 
[[Category:Drug]]

Latest revision as of 09:26, 1 February 2015

Template:Drug header

WikiDoc Resources for Vinblastine (patient information)

Articles

Most recent articles on Vinblastine (patient information)

Most cited articles on Vinblastine (patient information)

Review articles on Vinblastine (patient information)

Articles on Vinblastine (patient information) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Vinblastine (patient information)

Images of Vinblastine (patient information)

Photos of Vinblastine (patient information)

Podcasts & MP3s on Vinblastine (patient information)

Videos on Vinblastine (patient information)

Evidence Based Medicine

Cochrane Collaboration on Vinblastine (patient information)

Bandolier on Vinblastine (patient information)

TRIP on Vinblastine (patient information)

Clinical Trials

Ongoing Trials on Vinblastine (patient information) at Clinical Trials.gov

Trial results on Vinblastine (patient information)

Clinical Trials on Vinblastine (patient information) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Vinblastine (patient information)

NICE Guidance on Vinblastine (patient information)

NHS PRODIGY Guidance

FDA on Vinblastine (patient information)

CDC on Vinblastine (patient information)

Books

Books on Vinblastine (patient information)

News

Vinblastine (patient information) in the news

Be alerted to news on Vinblastine (patient information)

News trends on Vinblastine (patient information)

Commentary

Blogs on Vinblastine (patient information)

Definitions

Definitions of Vinblastine (patient information)

Patient Resources / Community

Patient resources on Vinblastine (patient information)

Discussion groups on Vinblastine (patient information)

Patient Handouts on Vinblastine (patient information)

Directions to Hospitals Treating Vinblastine (patient information)

Risk calculators and risk factors for Vinblastine (patient information)

Healthcare Provider Resources

Symptoms of Vinblastine (patient information)

Causes & Risk Factors for Vinblastine (patient information)

Diagnostic studies for Vinblastine (patient information)

Treatment of Vinblastine (patient information)

Continuing Medical Education (CME)

CME Programs on Vinblastine (patient information)

International

Vinblastine (patient information) en Espanol

Vinblastine (patient information) en Francais

Business

Vinblastine (patient information) in the Marketplace

Patents on Vinblastine (patient information)

Experimental / Informatics

List of terms related to Vinblastine (patient information)

IMPORTANT WARNING:

When vinblastine is administered into a vein, it may leak into surrounding tissue. Your doctor or nurse will monitor your administration site for this reaction.

About your treatment

Your doctor has ordered the drug vinblastine to help treat your illness. The drug is given by injection into a vein.

This medication is used to treat:

  • Hodgkin's disease
  • non-Hodgkin's lymphomas
  • mycosis fungoides
  • testicular cancer
  • Kaposi's sarcoma related to acquired immunodeficiency syndrome (AIDS)
  • Letterer-Siwe disease

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Vinblastine is in a class of drugs known as vinca alkaloids. It slows or stops the growth of cancer cells in your body. The length of treatment depends on the types of drugs you are taking, how well your body responds to them, and the type of cancer you have.

Other uses for this medicine

Vinblastine is also used to treat non-small cell lung cancer, bladder cancer, head and neck cancer, cervical cancer, idiopathic thrombocytopenia purpura, and autoimmune hemolytic anemia. Talk to your doctor about the possible risks of using this drug for your condition.

Precautions

Before taking vinblastine

  • tell your doctor and pharmacist if you are allergic to vinblastine or any other drugs.
  • tell your doctor and pharmacist what prescription and nonprescription medications you are taking, especially aspirin, itraconazole (Sporanox), phenytoin (Dilantin), and vitamins.
  • tell your doctor if you have or have ever had liver disease.

you should know that vinblastine may interfere with the normal menstrual cycle (period) in women and may stop sperm production in men. However, you should not assume that you cannot get pregnant or that you cannot get someone else pregnant. Women who are pregnant or breast-feeding should tell their doctors before they begin taking this drug. You should not plan to have children while receiving chemotherapy or for a while after treatments. (Talk to your doctor for further details.) Use a reliable method of birth control to prevent pregnancy. Vinblastine may harm the fetus.

  • do not have any vaccinations (e.g., measles or flu shots) without talking to your doctor.

Side Effects

Mild side effects

Side effects from vinblastine are common and include:

  • nausea and vomiting which usually lasts less than 24 hours
  • stomach pain
  • constipation
  • diarrhea
  • jaw pain, headache, or other aches
  • thinned or brittle hair
  • exposed areas of the skin may become easily sunburned

Tell your doctor if either of these symptoms is severe or lasts for several hours:

  • fatigue
  • mouth blistering

Severe side effects

If you experience any of the following symptoms, call your doctor immediately:

  • unusual bleeding or bruising
  • tingling, numbness, and cramping in the legs or arms for longer than a few days
  • severe abdominal or muscle cramping
  • difficulty walking
  • hoarseness
  • fever
  • chills
  • change in normal bowel habits for more than 2 days
  • sore throat or mouth
  • difficulty controlling bladder
  • increased, painful, or difficult urination
  • redness, pain, or swelling at the injection site

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/report.htm] or by phone [1-800-332-1088].

In case of emergency/overdose

In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.

Special instructions

The most common side effect of vinblastine is a decrease of blood cells. Your doctor may order tests before, during, and after your treatment to see if your blood cells are affected by the drug.

Brand names

  • Velban®

Template:WH Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Vinblastine_(patient_information)&oldid=1061580"